Next Article in Journal
Modulation of the Aryl Hydrocarbon Receptor Signaling Pathway Impacts on Junín Virus Replication
Next Article in Special Issue
Investigation of Dengue Infection in Asymptomatic Individuals during a Recent Outbreak in La Réunion
Previous Article in Journal
Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1(VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF
Previous Article in Special Issue
Genomic Analysis of West Nile Virus Lineage 1 Detected in Mosquitoes during the 2020–2021 Outbreaks in Andalusia, Spain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Human Arboviral Infections in Italy: Past, Current, and Future Challenges

by
Benedetta Rossi
1,
Filippo Barreca
2,†,
Domenico Benvenuto
2,†,
Neva Braccialarghe
2,†,
Laura Campogiani
1,†,
Alessandra Lodi
2,†,
Camilla Aguglia
2,
Rosario Alessandro Cavasio
2,
Maria Laura Giacalone
2,
Dimitra Kontogiannis
2,
Martina Moccione
2,
Vincenzo Malagnino
1,2,
Massimo Andreoni
1,2,
Loredana Sarmati
1,2 and
Marco Iannetta
1,2,*
1
Infectious Disease Clinic, Policlinico Tor Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy
2
Department of System Medicine Tor Vergata, University of Rome, Via Montpellier 1, 00133 Rome, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2023, 15(2), 368; https://doi.org/10.3390/v15020368
Submission received: 22 December 2022 / Revised: 23 January 2023 / Accepted: 24 January 2023 / Published: 27 January 2023
(This article belongs to the Special Issue State-of-the-Art Arbovirus Research in Europe 2022)

Abstract

:
Arboviruses represent a public health concern in many European countries, including Italy, mostly because they can infect humans, causing potentially severe emergent or re-emergent diseases, with epidemic outbreaks and the introduction of endemic circulation of new species previously confined to tropical and sub-tropical regions. In this review, we summarize the Italian epidemiology of arboviral infection over the past 10 years, describing both endemic and imported arboviral infections, vector distribution, and the influence of climate change on vector ecology. Strengthening surveillance systems at a national and international level is highly recommended to be prepared to face potential threats due to arbovirus diffusion.

1. Introduction

The acronym arbovirus derives from arthropod-borne viruses and refers to a variety of RNA viruses that share the unique characteristic of being transmitted to vertebrate hosts by hematophagous arthropods, including ticks, mosquitos, and sandflies [1].
Arboviruses represent a public health concern in Italy, mostly because they can infect humans, causing potentially severe emergent or re-emergent diseases. Furthermore, arboviruses have already been the cause of epidemic outbreaks in the last few decades in Italy, with the potential of introducing new species previously confined to tropical and sub-tropical regions [2]. Arboviral infections, such as those caused by West Nile Virus (WNV), Toscana Virus (TOSV), Sandfly Fever Sicily Virus (SFSV), Sandfly Fever Naples Virus (SFNV), Usutu Virus (USUV), and tick-borne encephalitis virus (TBEV), may be considered endemic in Italy; Chikungunya Virus (CHIKV), Dengue Virus (DENV), and Zika Virus (ZIKV) are under surveillance, as imported infections could lead to autochthonous outbreaks and subsequent endemic circulation in Italy [3]. Furthermore, global travel and climate changes may favor the circulation of arboviral infections [4].
Based on the evolving epidemiological situation and due to the increasing number of cases, the Italian Ministry of Health has activated a national surveillance system for arboviral diseases. This integrated surveillance system, coordinated by the Italian National Institute of Health (Istituto Superiore di Sanità, ISS) and the Zooprophylactic Institute of Abruzzo and Molise (IZS-AM), annually publishes bulletins to trace and tackle arboviral infections, to ensure early detection of autochthonous and imported cases and contain any possible spread [5].
In this narrative review, we aim to summarize the Italian epidemiology of arboviral infections over the past 10 years, to describe vector distribution in Italy, and possible new threats for the next future, also considering the influence of climate change.

2. Endemic Arboviruses in Italy

2.1. West Nile Virus and Usutu Virus

WNV and USUV are two flaviviruses whose diffusion in the Italian avian fauna has been well established for a long time. In recent decades, they have become relevant also for human health. WNV was isolated for the first time in Uganda in 1937 [6]. It encompasses five lineages, but only lineages 1 and 2 are associated with epidemics. Birds represent the main reservoir and become highly viremic when infected (amplifying host), allowing WNV transmission to mosquitoes of Culex species that feed on them. Infected mosquitoes can spread the virus to non-avian vertebrate hosts such as horses and humans, who develop a low-level viremia, usually insufficient to transmit the virus to other mosquitoes (dead-end host) [7] (Table 1).
In Italy, the first cases in horses were reported in 1998, while the first cases of the most severe form of WNV infection, West Nile neuroinvasive disease (WNND), were diagnosed in humans in 2008 [7,8,9]. Since 2008, an average of 60 human cases per year of WNV infections, including asymptomatic infection, febrile syndrome, and WNND, has been reported, with an increasing trend after 2011, presumably because of the introduction of lineage 2 in Italy [9]. Since 2018, a further increase in the number of cases has been reported, especially during summer. This phenomenon is sustained by both biotic factors, such as migratory birds that brought the virus to new regions and the high density of Culex mosquitoes, and abiotic factors, such as higher temperatures in spring and summer [10]. Sequencing of the WNV genome from infected humans, birds, and mosquitoes documented the persistence of the same viral strains in consecutive years in Italy, supporting the hypothesis of an overwintering capacity of WNV, rather than different introductions [11]. In 2022, there was a dramatic increase in the number of WNV cases, with 586 human infections reported by the European Centre for Disease Prevention and Control (eCDC) up to the 25th of November [12], and 588 human infections according to the ISS bulletin [13] up to the 2nd of November (Table 2). Most of the reported cases occurred in the Veneto region, where a new strain of WNV lineage 1 was introduced in 2021 and is currently co-circulating with WNV lineage 2. This strain of WNV lineage 1 seems to be associated with an increased rate of WNND [14].
Usutu virus (USUV) is an emerging flavivirus isolated in South Africa in 1959 and introduced in Tuscany, Italy, in 1996, retrieved from archived tissue samples from birds [15,16]. This arbovirus shares its transmission cycle with the phylogenetically related WNV, and recognizes Culex mosquitoes as the main vector, birds as the amplifier hosts, and mammals (including humans) as the dead-end hosts [15].
Although USUV has mostly been associated with diseases in birds, it can also infect mammals, including humans, with a wide spectrum of signs and symptoms, ranging from asymptomatic forms to severe neurological impairment, similar to the WNND [17] (Table 1). In 2009, the first two cases of confirmed human disease worldwide were reported in two immunosuppressed patients in Italy, both presenting with neuroinvasive disease [18,19]. In the following years, considering the implementation of surveillance systems, USUV was identified in an increasing number of susceptible hosts; it was detected in different native (mainly Culex pipiens) and invasive mosquito species (Aedes albopictus, Ae. japonicus), and a rise in USUV human infection notifications was observed in Europe [20]. In Italy, this led to the development of a WNV and USUV dedicated surveillance system in 2017. Between 2017 and 2018, USUV has been detected in five Italian regions (Emilia-Romagna, Friuli Venezia Giulia, Latium, Lombardy, and Veneto) [3]. Eight clinically relevant cases (only one with a neuroinvasive form) were identified in 2018 (Veneto) and two symptomatic cases in 2022 (Lombardy and Emilia-Romagna) [13,15] (Table 2). Although several lineages of USUV were identified (three African and five European) so far, four different lineages (Europe-1, 2, 3, and 4) seem to be prevalent in Italy. Considering USUV spatial spread in Europe, Italy seems to act mainly as a reservoir for USUV spread in neighboring countries, with two geographical clusters in northern and north-western regions [21].
USUV is often misidentified as WNV because of the cross-reactivity of serological assays, and new diagnostic tools are under development to improve diagnostic approaches [22,23]. Surveys conducted on blood donors and asymptomatic patients have shown a significant USUV seroprevalence in Italy, with some cases of detectable viremia in several Italian regions [13,22,24,25,26]; a higher USUV seroprevalence compared to WNV was found in the cerebrospinal fluid and sera of patients with neurologic impairment tested in Modena (Emilia-Romagna), suggesting an overall underreporting of the human USUV infection [27].

2.2. Toscana Virus, Sandfly Naples Virus, and Sandfly Sicilian Virus

Toscana Virus (TOSV) is a phlebovirus originally isolated in 1971 in Monte Argentario (Tuscany) from the sandflies Phlebotomus perniciosus and P. perfiliewi. [28].
It was recognized as the causative agent of neurological disease in humans only in 1983 [29]. Over the past two decades, circulation of TOSV has been detected mainly in the Mediterranean basin, typically between May and October, in humans and domestic animals [30]. A significant proportion of infections are asymptomatic; although, TOSV can reach the central nervous system (CNS) and cause acute aseptic meningitis, encephalitis, and meningoencephalitis. Other clinical manifestations associated with TOSV infection are described in Table 1. Severe forms with CNS involvement have been mainly reported in male adults, probably related to exposition during outdoor activities in the evening when phlebotomi are maximally active [30].
As described in Table 2, between June 2016 and October 2021, 331 confirmed cases of TOSV meningitis, meningoencephalitis, and encephalitis were reported in Italy, with 292 hospitalizations [31,32]. Even though earlier reports strongly confined TOSV infections within the Tuscany region, 61% of neuroinvasive cases occurred in Emilia Romagna, with an incidence rate two times higher than in other regions. This might be explained considering that Emilia-Romagna is located in the Po River Valley, which represents a fragile environment particularly vulnerable to climate variations. Indeed, changes in temperature and precipitation influence competent vector diffusion in this territory generating new favorable ecological niches for phlebotomi [33]. An elevated abundance of sandfly vectors has already been recorded in Emilia Romagna in previous studies on human leishmaniosis (phlebotomi are also vectors for Leishmania species) and further confirmed by recent entomological studies. The hilly environments in the central and eastern parts of the region are considered the most suitable areas to find abundant populations of sandflies [34,35].
Besides TOSV, two more sandfly-transmitted phleboviruses are endemic in Italy with a prevalent distribution in central and southern regions, namely, sandfly Naples virus (SFNV) and Sandfly Sicilian virus (SFSV) [36]. They were initially isolated in Italy, respectively, in Naples in 1944 and in Palermo (Sicily) in 1943; although, they are widely distributed in Southern Europe and other Mediterranean countries, reflecting the vectors’ distribution [37,38,39]. Phlebotomus perniciosus together with P. perfiliewi are the most efficient vectors for SFNV, whereas P. perniciosus and P. papatasi are able to transmit SFSV [40]. Classically, the symptomatic disease caused by SFNV and SFSV is a mild, self-resolving, flu-like illness, in which fever is always present (Table 1). No deaths associated with these phleboviruses have been reported, so far [41].

2.3. Tick-Borne Encephalitis Virus

Tick-born encephalitis (TBE) is an emerging zoonotic neurological disease caused by the tick-borne encephalitis virus (TBEV), which belongs to the flavivirus genus [42]. Among the known TBEV subtypes (European, Siberian, Far-Eastern, Baikalian, and Himalayan), the European one, which is the least virulent subtype, is the most diffuse in Italy and is transmitted by Ixodes ricinus [43]. The first cases of TBE in Italy were identified in Tuscany in the 1970s, whereas other sporadic foci were subsequently reported in the 1990s in the northern provinces of Trento (Trentino Alto Adige) and Belluno (Veneto), where the disease is now endemic [44]. As resumed in Table 1, clinical features range from asymptomatic or nonspecific flu-like symptoms to central nervous system complications in 20–30% of cases, such as severe meningoencephalomyelitis [45]. Italy is considered a low-incidence country for TBEV, mostly because of its restricted distribution to relatively small areas of the country, with sporadic cases in Emilia-Romagna, Tuscany, and Lazio. An endemic circulation is registered only in three main foci of the Triveneto area: the province of Trento (Trenino-Alto Adige), the pre-alpine Belluno province (Veneto), and the north-east of Friuli-Venezia Giulia. In this area, the number of cases has significantly increased over time, from 4.5 cases/year during the period 1975–2004 to 28 cases/year between 2000 and 2013 [46]. Although Italy is a country at low risk for TBE, the province of Belluno (Veneto), is classified by the World Health Organization (WHO) as a highly endemic area (>5 cases per 100,000 population), with an annual incidence of 5.95 cases per 100,000 population, according to the notifications received in the period 2015–2018 [44] (Table 2). A TBE vaccine is currently available for human use in Italy. Although official data on TBE vaccination rates in Italy are lacking, some reports suggest that vaccination coverage is low (10–40%), even in high-risk groups in highly endemic areas [44].

3. Imported Arboviruses and Outbreaks in Italy

Imported cases of infections due to arbovirus are commonly reported among travelers returning from endemic regions (Table 2). Moreover, in non-endemic areas where potentially competent vectors are present, the risk of autochthonous transmission after imported cases is relatively high. The continuous expansion of areas with arbovirus circulation, together with climate changes and the dispersion of competent vectors may increase the risk of outbreaks also in regions previously considered temperate climate areas [47].

3.1. Chikungunya Virus

CHIKV is a togavirus endemic in regions of Africa, South-East Asia, and in the Indian subcontinent, which has become established in the tropical Americas, and is transmitted by Aedes mosquitos. In Italy, the first cases were reported from July to September 2007 in Emilia Romagna, during an outbreak originating from a visitor from India, and subsequently sustained by autochthonous spread, with a total of 217 human cases and one death [48,49,50]. At that time, Aedes albopictus, which is a competent vector for CHIKV, was already established and abundant enough to sustain transmission following the introduction of the virus by an infected returning traveler. After this outbreak, only sporadic imported cases were reported in Italy, until 2013 (Table 2). In December 2013, an outbreak of CHIKV in the Western Hemisphere occurred in the Caribbean leading to the wide spread of the virus through the American continent. The virus was then imported into Europe by several viremic patients traveling from endemic countries [50]. During 2014, the number of imported cases of CHIKV registered in Italy increased up to 37 cases, including 18 cases connected to the Caribbean outbreak. In the following years, few imported cases were observed (Table 2). In 2017, a second autochthonous outbreak occurred in Italy, with 489 notified cases (270 confirmed and 219 probable), almost all confined to Latium and Calabria territories. It involved four outbreaks (Anzio, Latina, Rome, and Guardavalle Marina) sustained by a virus belonging to the Indian Ocean Lineage (IOL), with a hospitalization rate of 6% and one death [51,52]. This was the first known transmission of chikungunya in central and southern Italy [53]. In 2019, 18 cases of imported CHIKV from endemic regions (India 8%, Myanmar 23%, Congo 8%, Maldives 23%, and Brazil 38%) were registered [54]. In 2021, no cases of CHIKV were notified by the national surveillance of arboviral diseases, probably because of restriction measures adopted for the COVID-19 pandemic.

3.2. Dengue Virus

Dengue virus (DENV) is a flavivirus, responsible for the majority of febrile illnesses in tourists traveling in endemic areas, where it is mainly transmitted by Aedes aegypti [55] (Table 1). Travel-related cases of dengue fever in Europe reflect the evolution of dengue epidemiology in tropical regions, where the disease is endemic [56]. In Europe, DENV is not endemic despite the presence of competent vectors (Ae. albopictus), which may concur to establish new autochthonous cycles of infection [55]. In 2019, the highest number of imported cases of DENV (185) was observed in Italy. The subsequent decrease in the number of travel-related cases of dengue in Europe in 2020 (only 19 imported cases in Italy) can be explained by the implementation of restriction measures during the COVID-19 pandemic. The numbers of imported DENV cases per year in Italy (2010–2021) are summarized in Table 2. Moreover, all four DENV serotypes (1, 2, 3, and 4) have been identified in returning travelers in Italy [47]. No autochthonous dengue cases were described in Italy until 2020 [57]. During the summer of 2020, an autochthonous outbreak of DENV was documented in Italy, specifically in the Veneto region, with 11 autochthonous cases derived from a single imported case (index), of a young woman returning from Indonesia. Serotype 1 (DENV-1) was responsible for this outbreak [58].

3.3. Zika Virus

Zika virus (ZIKV) is a flavivirus transmitted to humans by Aedes mosquitos. Viremic travelers may cause autochthonous circulation after entering countries such as Italy, where competent vectors are present (for example, Ae. albopictus). Perinatal transmission and human-to-human transmission through blood transfusion and sexual intercourse have also been reported [59]. The first two cases of ZIKV infections imported in Italy were described in returning travelers from French Polynesia (January, 2014) [60]. ZIKV was previously limited to sporadic cases in Africa and Asia. In 2015, Zika virus caused an outbreak in Brazil, which involved 1,300,000 people, then spread rapidly throughout tropical South and Central America, and several imported cases were described in the USA and European countries, including Italy (102 cases in 2016) [59,61]. A few autochthonous cases of ZIKV have been documented in Italy, probably related to sexual rather than vector-related transmission [62,63] (Table 2).

4. Vectors and Climate Changes: The Italian Situation

Multiple anthropogenic factors, including land-use changes and global trade, together with warming and precipitation changes can influence the abundance of vectors and reservoir hosts for several arboviruses, thus exacerbating the risk of vector-borne (VBDs) and tick-borne diseases (TBDs). Indeed, in Italy in the last decades, several VBDs have emerged unexpectedly because climate changes have already contributed to generate suitable conditions for stable arthropod vector replication and arbovirus transmission [4].

4.1. Mosquitos

Mosquitos are small flies belonging to the family of Culicidae, which play a primary role in arbovirus transmission because of their widespread diffusion. In Italy, both invasive (Aedes) and native species (Culex) are present.

4.1.1. Aedes

According to the current surveillance system, five invasive Aedes mosquito species have been identified as having steadily established in Europe, namely, Ae. albopictus, Ae. aegypti, Ae. japonicus, Ae. Atropalpus, and Ae. koreicus. Among this group of culicidae, the two most prevalent species representing a public health issue in Europe are Ae. aegypti and Ae. albopictus [64].
Ae. aegypti evolved in sub-Saharan Africa, and appeared for the first time in many southern European countries and the Americas at the end of the 1700s, imported through the slave trade. Although Ae. aegypti disappeared from temperate zones during winter because it does not enter into diapause and cannot survive the winter, subsequent reintroductions in temperate zones were due to sailing ships during summer. During the 1900s, an expansion outside the original geographical area was observed, mainly because of trades and troop movements during World War II. Nevertheless, Ae. aegypti is still not present in Italy [65]. Ae. aegypti has an increased ability to spread diseases compared to Ae. albopictus, considering its feeding patterns, characterized by several human blood meals from multiple individuals in a short period of time. Moreover, Ae. aegypty has better vector competence for chikungunya (CHIKV) and dengue (DENV) viruses compared to Ae. Albopictus, and it is also the principal vector for Yellow Fever Virus (YFV) [66].
Ae. albopictus, commonly called the Asian tiger mosquito, is native to tropical forests in South Asia. It is already established in most regions of southern Europe, with Albania and Italy being the first colonized countries in 1979 and 1990, respectively. Ae. albopictus spread was related to tires and ornamental plants containing mosquito eggs and exported from endemic areas of Asia. Ae. albopictus is a competent vector for CHIKV, DENV, and filarial parasites (Dirofilaria species, which primarily parasites dogs but can also affect humans). Experimental studies have demonstrated that Ae. albopictus can also be a competent vector for West Nile Virus [66]. Maps describing current Ae. aegypti and Ae. albopictus distributions in Europe are also available [67,68].
Both Aedes species are highly anthropophilic and daytime biters, with peak activity at dawn and dusk. They compete for the same habitats, sharing mostly urban and peri-urban areas; although, Ae. albopictus has a cooler thermal optimum (26 °C) than Ae. aegypti (29 °C), and is more ecologically flexible, living also in rural, residential, and agricultural habitats. For these reasons Ae. albopictus is frequently found in temperate zones [69,70]. Furthermore, it bites humans and a wide range of mammals and birds that are not susceptible to the arboviruses they carry. Conversely, Ae. aegypti exclusively feeds on humans.
A new mosquito species native to South Asia, Aedes koreicus, was detected in Italy in 2011, and in other European countries such as Belgium, Switzerland, Germany, Hungary Slovenia, and Russia [71]. Considering its ability to adapt to temperate climates, it can compete with Ae. albopictus; although, it seems unlikely that Ae. koreicus could replace Ae. albopictus [72]. In northern Italy, Ae. koreicus has also colonized mountainous districts in the Veneto region, where Ae. albopictus remains absent. With the establishment of this new mosquito, humans and other mammals could face new potential threats, considering that experimental data have demonstrated the ability of Ae. koreicus to transmit Japanese encephalitis virus (JEV), and two other already endemic flaviviruses in the Veneto region: WNV and USUV [69,71,72].

4.1.2. Culex

The genus Culex is of high medical and veterinary interest due to its widespread distribution; it encompasses 768 species divided among 26 subgenera able to transmit a wide range of pathogens, causing diseases in both animals and humans [73].
Mosquitoes in the Cx. pipiens complex (or assemblage) are native to Africa, Asia, and Europe; although, they are currently distributed worldwide. Cx. pipiens complex includes different taxa: Cx. pipiens and Cx. quinquefasciatus, mostly distributed in temperate and tropical areas, as well as Cx. australicus and Cx. globocoxitus, only present in Australia. The taxon Cx. pipiens has two different biotypes: the Cx. pipiens pipiens, and the Cx. pipiens molestus. The two biotypes differ in behavioral and ecological characteristics: the pipiens biotype, also known as the rural form, is highly ornithophilic, even though several studies also demonstrated potential anthropophilic behavior [74]; it lays eggs in open-air spaces and the females hibernate during winter (diapause). The molestus biotype, also known as the urban form, is anthropophilic even though it can also bite other mammals; it does not require large habitat for oviposition and does not diapause [75].
In Italy, Cx. pipiens mosquitoes are present and outspread, and they represent competent vectors for both WNV and USUV transmission [76]. Outside Europe, Culex mosquitos are also competent for Rift Valley Fever, (RVFV), Japanese encephalitis virus (JEV), Sindbis virus (SINV), and Tahyna virus (TAHV) [77,78], which can cause severe human diseases.

4.2. Phlebotomine Sandflies

Phlebotomine sandflies are responsible for the transmission of a few types of parasites between humans and nonhuman animal reservoirs and they represent important vectors for arboviral infections [75,79]. They belong to the Diptera order, Psychodidae family, and are small insects with sand-like color (hence, the name “sand flies”) [80]. Only the females are hematophagous and have no specific host preference since they mostly bite any warm-blooded vertebrate (the Sergentomyia genus feeds mainly on reptiles). Mating occurs after the blood meal or in the presence of a host to sting, and the eggs are subsequently laid. They live in domestic, peri-domestic, and wild environments, being generally active during twilight and night hours, avoiding sunlight, and hiding in cool and humid environments such as stables, houses, chicken coops, and cracks of walls, rock, and soil. Phlebotomine are quite spread in the Mediterranean basin and the Middle East, and colonization by passive transport from distant regions has never been reported [80].
Out of the over 800 described species of Phlebotomine, 8 species are endemic in Italy, and they belong to 2 genera: Phlebotomus and Sergentomyia. Seven species belong to the Phlebotomus genus (P. perniciosus, P. perfiliewi, P. neglectus, P. ariasi, P. papatasi, P. sergenti, and P. mascitti), and one species belongs to the Sergentomyia genus (S. minuta). This latter species feeds on cold-blooded animals and does not cause diseases in humans, but it can be an important ecological indicator of the presence of Phlebotomine [81]. The most widespread and most abundant species in Italy is P. perniciosus, an established vector for visceral leishmaniasis, and also competent for Toscana virus (TOSV) and Sandfly Fever Naples virus (SFNV) [82]. TOSV was isolated also in P. perfiliewi, while SFSV was isolated in P. papatasi [38,83].

4.3. Ticks

The most widespread and relevant species of ticks in Italy are Ixodes ricinus (the wood tick), Rhipicephalus sanguineus (the dog tick), Hyalomma marginatum, and Dermacentor reticulatus [84].

4.3.1. Ixodes

Ticks from the Ixodidate family are vectors for several tick-borne flaviviruses such as tick-borne encephalitis virus (TBEV), Powassan virus (POWV), and Omsk hemorrhagic fever virus, and bunyaviruses such as Crimean-Congo hemorrhagic fever virus (CCHFV), all agents of human diseases that could lead to fatal complications such as viral hemorrhagic fever (VHF) [85,86]. In particular, I. ricinus acts both as vector and reservoir for several bacterial, viral, and protozoan agents causing animal and human diseases in Europe [87]. In Italy, it has been detected in most northern and central regions, especially in woods and shrubby habitats where the relative humidity allows the tick to complete its 3-year developmental cycle. It is the most competent vector for TBEV in Europe. As previously described, in recent years, there has been an increase in TBE cases in Italy. Rizzoli et al. have shown that this increase is not directly associated with changes in climate variables. Conversely, changes in the vegetation that make the habitat more suitable for small mammals, which represent TBEV reservoirs, seem to best predict the increase in TBE incidence [88]. A phylogenetic analysis of TBEV Italian isolates suggested that the different TBEV strains originated independently after different introductions from neighboring countries, presumably through migratory birds [43].

4.3.2. Hyalomma

Ticks belonging to the Hyalomma genus, in which immature stages are strictly associated with birds, can potentially acquire WNV and USUV from an infected host and possibly act as vectors, as demonstrated experimentally [89]. Migratory birds can carry infected ticks, as well as non-endemic pathogens such as Rickettsia africae, from sub-Saharan Africa, into Europe [90]. With climate changes, the likelihood of the establishment of permanent Hyalomma populations in central and northern Europe is increasing [91].

4.4. The Impact of Climate Changes on VBDs and TBDs

VBDs and TBDs are highly climate-sensitive because the vectors are poikilotherms (body temperature fluctuates accordingly to environmental temperature), and the rate of most physiological activities such as digestion of blood meals, egg-laying, and refeeding is regulated by ambient temperature [92]. Additionally, vector ranges, distribution, and seasonality are already altered because of changes in weather conditions, particularly temperatures, precipitation, and humidity. In its sixth assessment report, the Intergovernmental Panel on Climate Change (IPCC) stated with high confidence that the prevalence of vector-borne diseases has increased in recent decades. Arboviral infections such as dengue and West Nile, together with malaria and Lyme disease, are expected to further increase over the next 80 years if measures are not taken to adapt and strengthen control strategies [93]. Understanding the extent of the influence of climate change on the distribution and frequency of arthropod vectors and arboviral infection is still challenging, considering the high number of factors with complex intertwine that can contribute to these changes. Moreover, it is difficult to distinguish natural climate variability from anthropogenic-driven environmental change. Despite these complexities, the different aspects of vector-borne disease, including pathogens, vectors, and reservoir hosts, are highly responsive to environmental modifications. Indeed, changes in the rates of vector-borne diseases at given locations are often associated with concomitant changes in the local environmental conditions [4].

5. Conclusions and Future Directions

Arthropods and viruses are evolving organisms that react to ecological and anthropogenic factors, in an attempt to adapt to a modified environment with new selective pressures. Global concern about the spread of arboviruses to new geographical areas is rising. In Italy and in other regions of southern Europe, the possibility of autochthonous transmission of non-endemic arboviral infections, such as dengue and chikungunya, has already been documented. Moreover, the global spread of arthropods together with a continuous intensification of human movements can contribute to the introduction of new vectors and tick-borne diseases in previously unaffected countries. One example could be the possible introduction of the Crimean-Congo hemorrhagic fever virus (CCHFV) in Italy, through migratory birds and ticks. Indeed, CCHFV human infections have already been identified in the former Soviet Union and some Balkan countries and more recently in western Spain (first two cases in 2016). Since 2016, at least 10 confirmed cases of human infection have been reported in Spain, and studies on ticks have demonstrated that CCHFV is widespread in the country [94]. Considering that CCHFV has extended from Eastern to Western Europe, it is reasonable to hypothesize that this virus could reach Italy.
Countries that potentially have the conditions for the introduction of arthropod-related emerging diseases need to strengthen surveillance systems to face these new threats.

Author Contributions

Conceptualization, B.R., M.I., M.A., V.M. and L.S.; methodology, B.R., M.I., and V.M.; writing—original draft preparation, B.R., F.B., D.B., N.B., A.L., C.A., R.A.C., M.L.G., D.K. and M.M.; writing—review and editing, B.R, M.I., L.C., V.M. and L.S.; supervision, M.I., L.C., V.M. and L.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest relative to this work.

References

  1. García-Sastre, A.; Endy, T.P. Arboviruses. In Encyclopedia of Microbiology; Elsevier: Amsterdam, The Netherlands, 2009; pp. 313–321. ISBN 978-0-12-373944-5. [Google Scholar]
  2. Takken, W.; van den Berg, H. Manual on Prevention of Establishment and Control of Mosquitoes of Public Health Importance in the WHO European Region (with Special Reference to Invasive Mosquitoes); WHO Regional Office for Europe: Copenhagen, Denmark, 2019. [Google Scholar]
  3. Ministero della Salute. Piano Nazionale Di Prevenzione, Sorveglianza e Risposta Alle Arbovirosi (PNA) 2020–2025; Ministero della Salute: Rome, Italy, 2019.
  4. Thomson, M.C.; Stanberry, L.R. Climate Change and Vectorborne Diseases. N. Engl. J. Med. 2022, 387, 1969–1978. [Google Scholar] [CrossRef] [PubMed]
  5. Istituto Superiore Di Sanità. EpiCentro—Epidemiology for Public Health; Istituto Superiore Di Sanità: Rome, Italy, 2022. [Google Scholar]
  6. Barzon, L.; Pacenti, M.; Franchin, E.; Squarzon, L.; Lavezzo, E.; Cattai, M.; Cusinato, R.; Palù, G. The Complex Epidemiological Scenario of West Nile Virus in Italy. Int. J. Environ. Res. Public Health 2013, 10, 4669–4689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Delbue, S.; Ferrante, P.; Mariotto, S.; Zanusso, G.; Pavone, A.; Chinaglia, M.; L’Erario, R.; Monaco, S.; Ferrari, S. Review of West Nile Virus Epidemiology in Italy and Report of a Case of West Nile Virus Encephalitis. J. Neurovirol. 2014, 20, 437–441. [Google Scholar] [CrossRef] [PubMed]
  8. Riccardo, F.; Bella, A.; Monaco, F.; Ferraro, F.; Petrone, D.; Mateo-Urdiales, A.; Andrianou, X.D.; Del Manso, M.; Venturi, G.; Fortuna, C.; et al. Rapid Increase in Neuroinvasive West Nile Virus Infections in Humans, Italy, July 2022. Eurosurveillance 2022, 27, 2200653. [Google Scholar] [CrossRef] [PubMed]
  9. Moirano, G.; Richiardi, L.; Calzolari, M.; Merletti, F.; Maule, M. Recent Rapid Changes in the Spatio-temporal Distribution of West Nile Neuro-invasive Disease in Italy. Zoonoses Public Health 2020, 67, 54–61. [Google Scholar] [CrossRef]
  10. Rizzoli, A.; Jiménez-Clavero, M.A.; Barzon, L.; Cordioli, P.; Figuerola, J.; Koraka, P.; Martina, B.; Moreno, A.; Nowotny, N.; Pardigon, N.; et al. The Challenge of West Nile Virus in Europe: Knowledge Gaps and Research Priorities. Eurosurveillance 2015, 20, 21135. [Google Scholar] [CrossRef] [Green Version]
  11. Marini, G.; Manica, M.; Delucchi, L.; Pugliese, A.; Rosà, R. Spring Temperature Shapes West Nile Virus Transmission in Europe. Acta Trop. 2021, 215, 105796. [Google Scholar] [CrossRef]
  12. European Centre for Disease Prevention and Control. Weekly Updates: 2022 West Nile Virus Transmission Season; European Centre for Disease Prevention and Control: Stockholm, Sweden, 2022. [Google Scholar]
  13. ISS; IZS Teramo. Sorveglianza Integrata Del West Nile e Usutu Virus; Bollettino N. 20 Del 2 Novembre 2022 RISULTATI NAZIONALI; ISS: Rome, Italy; IZS Teramo: Teramo, Italy, 2022. [Google Scholar]
  14. Barzon, L.; Pacenti, M.; Montarsi, F.; Fornasiero, D.; Gobbo, F.; Quaranta, E.; Monne, I.; Fusaro, A.; Volpe, A.; Sinigaglia, A.; et al. Rapid Spread of a New West Nile Virus Lineage 1 Associated with Increased Risk of Neuroinvasive Disease during a Large Outbreak in Northern Italy, 2022: One Health Analysis. J. Travel Med. 2022, taac125. [Google Scholar] [CrossRef]
  15. Pacenti, M.; Sinigaglia, A.; Martello, T.; De Rui, M.E.; Franchin, E.; Pagni, S.; Peta, E.; Riccetti, S.; Milani, A.; Montarsi, F.; et al. Clinical and Virological Findings in Patients with Usutu Virus Infection, Northern Italy, 2018. Eurosurveillance 2019, 24, 1900180. [Google Scholar] [CrossRef] [Green Version]
  16. Weissenböck, H.; Bakonyi, T.; Rossi, G.; Mani, P.; Nowotny, N. Usutu Virus, Italy, 1996. Emerg. Infect. Dis. 2013, 19, 274–277. [Google Scholar] [CrossRef]
  17. Vázquez, A.; Jiménez-Clavero, M.A.; Franco, L.; Donoso-Mantke, O.; Sambri, V.; Niedrig, M.; Zeller, H.; Tenorio, A. Usutu Virus—Potential Risk of Human Disease in Europe. Eurosurveillance 2011, 16, 19935. [Google Scholar] [CrossRef] [PubMed]
  18. Cavrini, F.; Gaibani, P.; Longo, G.; Pierro, A.M.; Rossini, G.; Bonilauri, P.; Gerunda, G.E.; Gerundi, G.E.; Di Benedetto, F.; Pasetto, A.; et al. Usutu Virus Infection in a Patient Who Underwent Orthotropic Liver Transplantation, Italy, August–September 2009. Eurosurveillance 2009, 14, 19448. [Google Scholar] [CrossRef] [PubMed]
  19. Pecorari, M.; Longo, G.; Gennari, W.; Grottola, A.; Sabbatini, A.; Tagliazucchi, S.; Savini, G.; Monaco, F.; Simone, M.; Lelli, R.; et al. First Human Case of Usutu Virus Neuroinvasive Infection, Italy, August-September 2009. Eurosurveillance 2009, 14, 19446. [Google Scholar] [CrossRef] [PubMed]
  20. Vilibic-Cavlek, T.; Petrovic, T.; Savic, V.; Barbic, L.; Tabain, I.; Stevanovic, V.; Klobucar, A.; Mrzljak, A.; Ilic, M.; Bogdanic, M.; et al. Epidemiology of Usutu Virus: The European Scenario. Pathogens 2020, 9, 699. [Google Scholar] [CrossRef]
  21. Zecchin, B.; Fusaro, A.; Milani, A.; Schivo, A.; Ravagnan, S.; Ormelli, S.; Mavian, C.; Michelutti, A.; Toniolo, F.; Barzon, L.; et al. The Central Role of Italy in the Spatial Spread of USUTU Virus in Europe. Virus Evol. 2021, 7, veab048. [Google Scholar] [CrossRef]
  22. Caracciolo, I.; Mora-Cardenas, E.; Aloise, C.; Carletti, T.; Segat, L.; Burali, M.S.; Chiarvesio, A.; Totis, V.; Avšič–Županc, T.; Mastrangelo, E.; et al. Comprehensive Response to Usutu Virus Following First Isolation in Blood Donors in the Friuli Venezia Giulia Region of Italy: Development of Recombinant NS1-Based Serology and Sensitivity to Antiviral Drugs. PLoS Negl. Trop. Dis. 2020, 14, e0008156. [Google Scholar] [CrossRef] [Green Version]
  23. Percivalle, E.; Cassaniti, I.; Sarasini, A.; Rovida, F.; Adzasehoun, K.M.G.; Colombini, I.; Isernia, P.; Cuppari, I.; Baldanti, F. West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors. Viruses 2020, 12, 157. [Google Scholar] [CrossRef] [Green Version]
  24. Percivalle, E.; Sassera, D.; Rovida, F.; Isernia, P.; Fabbi, M.; Baldanti, F.; Marone, P. Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy. Vector Borne Zoonotic Dis. 2017, 17, 658–661. [Google Scholar] [CrossRef] [PubMed]
  25. Gaibani, P.; Pierro, A.; Alicino, R.; Rossini, G.; Cavrini, F.; Landini, M.P.; Sambri, V. Detection of Usutu-Virus-Specific IgG in Blood Donors from Northern Italy. Vector Borne Zoonotic Dis. 2012, 12, 431–433. [Google Scholar] [CrossRef] [PubMed]
  26. Carletti, F.; Colavita, F.; Rovida, F.; Percivalle, E.; Baldanti, F.; Ricci, I.; De Liberato, C.; Rosone, F.; Messina, F.; Lalle, E.; et al. Expanding Usutu Virus Circulation in Italy: Detection in the Lazio Region, Central Italy, 2017 to 2018. Eurosurveillance 2019, 24, 1800649. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Grottola, A.; Marcacci, M.; Tagliazucchi, S.; Gennari, W.; Di Gennaro, A.; Orsini, M.; Monaco, F.; Marchegiano, P.; Marini, V.; Meacci, M.; et al. Usutu Virus Infections in Humans: A Retrospective Analysis in the Municipality of Modena, Italy. Clin. Microbiol. Infect. 2017, 23, 33–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Verani, P.; Ciufolini, M.G.; Nicoletti, L.; Balducci, M.; Sabatinelli, G. Studi Ecologici Ed Epidemiologici Del Virus Toscana, Un Arbovirus Isolato Da Flebotomi [Ecological and Epidemiological Studies of Toscana Virus, an Arbovirus Isolated from Phlebotomus]. Ann. Dell’istituto Super. Di Sanita 1982, 18, 397–399. [Google Scholar]
  29. Renzi, A.; Caciolli, S.; Nicoletti, L.; Bartolozzi, D.; Balducci, M.; Traini, E.; Leoncini, F.; Baldereschi, M.; Paci, P.; Padovani, P.; et al. Central Nervous System Involvement during Infection by Phlebovirus Toscana of Residents in Natural Foci in Central Italy (1977–1988). Am. J. Trop. Med. Hyg. 1991, 45, 429–434. [Google Scholar] [CrossRef]
  30. Mellace, F.; Del Manso, M.; Oradini-Alacreu, A.; Ceccarelli, E.; Mateo-Urdiales, A.; Petrone, D.; Bella, A.; Caporali, M.G.; Bongiorno, G.; Bernardini, I.; et al. Meningiti, meningo-encefaliti ed encefaliti da virus Toscana in Italia, 2016–2021: Punta dell’iceberg di una arbovirosi endemica poco conosciuta. Boll. Epidemiol. Naz. 2022, 3, 10–19. [Google Scholar] [CrossRef]
  31. Gori Savellini, G.; Gandolfo, C.; Cusi, M.G. Epidemiology of Toscana Virus in South Tuscany over the Years 2011–2019. J. Clin. Virol. 2020, 128, 104452. [Google Scholar] [CrossRef]
  32. Pugliese, A.; Beltramo, T.; Torre, D. Seroprevalence Study of Tick-Borne Encephalitis, Borrelia Burgdorferi, Dengue and Toscana Virus in Turin Province. Cell Biochem. Funct. 2007, 25, 185–188. [Google Scholar] [CrossRef] [PubMed]
  33. Riccò, M.; Peruzzi, S. Epidemiology of Toscana Virus in Italy (2018–2020), a Summary of Available Evidences. Acta Biomed. Atenei Parm. 2021, 92, e2021230. [Google Scholar] [CrossRef]
  34. Calzolari, M.; Romeo, G.; Munari, M.; Bonilauri, P.; Taddei, R.; Sampieri, M.; Bariselli, S.; Rugna, G.; Dottori, M. Sand Flies and Pathogens in the Lowlands of Emilia-Romagna (Northern Italy). Viruses 2022, 14, 2209. [Google Scholar] [CrossRef] [PubMed]
  35. Maroli, M.; Rossi, L.; Baldelli, R.; Capelli, G.; Ferroglio, E.; Genchi, C.; Gramiccia, M.; Mortarino, M.; Pietrobelli, M.; Gradoni, L. The Northward Spread of Leishmaniasis in Italy: Evidence from Retrospective and Ongoing Studies on the Canine Reservoir and Phlebotomine Vectors: Spread of Leishmaniasis in Italy. Trop. Med. Int. Health 2008, 13, 256–264. [Google Scholar] [CrossRef]
  36. Marchi, S.; Trombetta, C.M.; Kistner, O.; Montomoli, E. Seroprevalence Study of Toscana Virus and Viruses Belonging to the Sandfly Fever Naples Antigenic Complex in Central and Southern Italy. J. Infect. Public Health 2017, 10, 866–869. [Google Scholar] [CrossRef]
  37. Palacios, G.; Tesh, R.B.; Savji, N.; Travassos da Rosa, A.P.A.; Guzman, H.; Bussetti, A.V.; Desai, A.; Ladner, J.; Sanchez-Seco, M.; Lipkin, W.I. Characterization of the Sandfly Fever Naples Species Complex and Description of a New Karimabad Species Complex (Genus Phlebovirus, Family Bunyaviridae). J. Gen. Virol. 2014, 95, 292–300. [Google Scholar] [CrossRef] [PubMed]
  38. Papa, A. Emerging Arboviral Human Diseases in Southern Europe. J. Med. Virol. 2017, 89, 1315–1322. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Izri, A.; Temmam, S.; Moureau, G.; Hamrioui, B.; de Lamballerie, X.; Charrel, R.N. Sandfly Fever Sicilian Virus, Algeria. Emerg. Infect. Dis. 2008, 14, 795–797. [Google Scholar] [CrossRef]
  40. 2020. Available online: https://www.ecdc.europa.eu/en/disease-vectors/facts/phlebotomine-sand-flies (accessed on 1 December 2022).
  41. Nicoletti, L.; Ciufolini, M.G. Rift Valley Fever and Other Phleboviruses. In Encyclopedia of Virology; Elsevier: Amsterdam, The Netherlands, 2008; pp. 490–497. ISBN 978-0-12-374410-4. [Google Scholar]
  42. Riccardi, N.; Antonello, R.M.; Luzzati, R.; Zajkowska, J.; Di Bella, S.; Giacobbe, D.R. Tick-Borne Encephalitis in Europe: A Brief Update on Epidemiology, Diagnosis, Prevention, and Treatment. Eur. J. Intern. Med. 2019, 62, 1–6. [Google Scholar] [CrossRef]
  43. Alfano, N.; Tagliapietra, V.; Rosso, F.; Ziegler, U.; Arnoldi, D.; Rizzoli, A. Tick-Borne Encephalitis Foci in Northeast Italy Revealed by Combined Virus Detection in Ticks, Serosurvey on Goats and Human Cases. Emerg. Microbes Infect. 2020, 9, 474–484. [Google Scholar] [CrossRef]
  44. Panatto, D.; Domnich, A.; Amicizia, D.; Reggio, P.; Iantomasi, R. Vaccination against Tick-Borne Encephalitis (TBE) in Italy: Still a Long Way to Go. Microorganisms 2022, 10, 464. [Google Scholar] [CrossRef] [PubMed]
  45. Barp, N.; Trentini, A.; Di Nuzzo, M.; Mondardini, V.; Francavilla, E.; Contini, C. Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection. Parasite Epidemiol. Control. 2020, 10, e00160. [Google Scholar] [CrossRef]
  46. Rezza, G.; Farchi, F.; Pezzotti, P.; Ruscio, M.; Lo Presti, A.; Ciccozzi, M.; Mondardini, V.; Paternoster, C.; Bassetti, M.; Merelli, M.; et al. Tick-Borne Encephalitis in North-East Italy: A 14-Year Retrospective Study, January 2000 to December 2013. Eurosurveillance 2015, 20, 30034. [Google Scholar] [CrossRef] [Green Version]
  47. The Arbovirus Working Group; Fortuna, C.; Remoli, M.E.; Rizzo, C.; Benedetti, E.; Fiorentini, C.; Bella, A.; Argentini, C.; Farchi, F.; Castilletti, C.; et al. Imported Arboviral Infections in Italy, July 2014–October 2015: A National Reference Laboratory Report. BMC Infect. Dis. 2017, 17, 216. [Google Scholar] [CrossRef] [Green Version]
  48. Rezza, G.; Nicoletti, L.; Angelini, R.; Romi, R.; Finarelli, A.; Panning, M.; Cordioli, P.; Fortuna, C.; Boros, S.; Magurano, F.; et al. Infection with Chikungunya Virus in Italy: An Outbreak in a Temperate Region. Lancet 2007, 370, 1840–1846. [Google Scholar] [CrossRef] [PubMed]
  49. Watson, R. Chikungunya Fever Is Transmitted Locally in Europe for First Time. BMJ 2007, 335, 532–533. [Google Scholar] [CrossRef] [Green Version]
  50. Rossini, G.; Gaibani, P.; Vocale, C.; Finarelli, A.C.; Landini, M.P. Increased Number of Cases of Chikungunya Virus (CHIKV) Infection Imported from the Caribbean and Central America to Northern Italy, 2014. Epidemiol. Infect. 2016, 144, 1912–1916. [Google Scholar] [CrossRef] [Green Version]
  51. Available online: https://portale.fnomceo.it/wp-content/uploads/import/201801/161227_draft_circolare_chikungunya_26_09_2017_rev_fm_lv_cr-1.pdf (accessed on 22 December 2022).
  52. Vairo, F.; Di Pietrantonj, C.; Pasqualini, C.; Mammone, A.; Lanini, S.; Nicastri, E.; Castilletti, C.; Ferraro, F.; Di Bari, V.; Puro, V.; et al. The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy. Viruses 2018, 10, 501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Available online: https://www.ecdc.europa.eu/en/publications-data/chikungunya-virus-disease-annual-epidemiological-report-2019 (accessed on 15 December 2022).
  54. Available online: https://www.epicentro.iss.it/arbovirosi/pdf/chik_2019.pdf (accessed on 15 December 2022).
  55. Burdino, E.; Milia, M.G.; Sergi, G.; Gregori, G.; Allice, T.; Cazzato, M.L.; Lucchini, A.; Lipani, F.; Calleri, G.; Orofino, G.; et al. Diagnosis of Dengue Fever in North West Italy in Travelers from Endemic Areas: A Retrospective Study. J. Clin. Virol. 2011, 51, 259–263. [Google Scholar] [CrossRef] [PubMed]
  56. Pierro, A.; Varani, S.; Rossini, G.; Gaibani, P.; Cavrini, F.; Finarelli, A.C.; Macini, P.; Cagarelli, R.; Mattivi, A.; Angelini, P.; et al. Imported Cases of Dengue Virus Infection: Emilia-Romagna, Italy, 2010. Clin. Microbiol. Infect. 2011, 17, 1349–1352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. 2020. Available online: https://www.ecdc.europa.eu/en/publications-data/dengue-annual-epidemiological-report-2020 (accessed on 1 December 2022).
  58. Barzon, L.; Gobbi, F.; Capelli, G.; Montarsi, F.; Martini, S.; Riccetti, S.; Sinigaglia, A.; Pacenti, M.; Pavan, G.; Rassu, M.; et al. Autochthonous Dengue Outbreak in Italy 2020: Clinical, Virological and Entomological Findings. J. Travel Med. 2021, 28, taab130. [Google Scholar] [CrossRef]
  59. Plourde, A.R.; Bloch, E.M. A Literature Review of Zika Virus. Emerg. Infect. Dis. 2016, 22, 1185–1192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Zammarchi, L.; Stella, G.; Mantella, A.; Bartolozzi, D.; Tappe, D.; Günther, S.; Oestereich, L.; Cadar, D.; Muñoz-Fontela, C.; Bartoloni, A.; et al. Zika Virus Infections Imported to Italy: Clinical, Immunological and Virological Findings, and Public Health Implications. J. Clin. Virol. 2015, 63, 32–35. [Google Scholar] [CrossRef]
  61. Available online: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&codLeg=64314&parte=1&serie= (accessed on 15 December 2022).
  62. Venturi, G.; Zammarchi, L.; Fortuna, C.; Remoli, M.E.; Benedetti, E.; Fiorentini, C.; Trotta, M.; Rizzo, C.; Mantella, A.; Rezza, G.; et al. An Autochthonous Case of Zika Due to Possible Sexual Transmission, Florence, Italy, 2014. Eurosurveillance 2016, 21, 30148. [Google Scholar] [CrossRef]
  63. Grossi, P.A.; Percivalle, E.; Campanini, G.; Sarasini, A.; Premoli, M.; Zavattoni, M.; Girello, A.; Dalla Gasperina, D.; Balsamo, M.L.; Baldanti, F.; et al. An Autochthonous Sexually Transmitted Zika Virus Infection in Italy 2016. New Microbiol. 2017, 1, 80–82. [Google Scholar]
  64. European Centre for Disease Prevention and Control. Vector Control with a Focus on Aedes Aegypti and Aedes Albopictus Mosquitoes: Literature Review and Analysis; Publications Office: Luxembourg, 2017. [Google Scholar]
  65. Da Re, D.; Montecino-Latorre, D.; Vanwambeke, S.O.; Marcantonio, M. Will the Yellow Fever Mosquito Colonise Europe? Assessing the Re-Introduction of Aedes Aegypti Using a Process-Based Population Dynamical Model. Ecological Informatics 2021, 61, 101180. [Google Scholar] [CrossRef]
  66. Schaffner, F.; Medlock, J.M.; Bortel, W.V. Public Health Significance of Invasive Mosquitoes in Europe. Clin. Microbiol. Infect. 2013, 19, 685–692. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Aedes Aegypti—Current Known Distribution: March 2021. Available online: https://www.ecdc.europa.eu/en/publications-data/aedes-aegypti-current-known-distribution-march-2021 (accessed on 22 January 2023).
  68. Aedes Albopictus—Current Known Distribution: March 2021. Available online: https://www.ecdc.europa.eu/en/publications-data/aedes-albopictus-current-known-distribution-march-2021 (accessed on 22 January 2023).
  69. Gossner, C.M. Increased Risk for Autochthonous Vector-Borne Infections Transmitted by Aedes Albopictus in Continental Europe. Eurosurveillance 2018, 23, 1800268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Ryan, S.J.; Carlson, C.J.; Mordecai, E.A.; Johnson, L.R. Global Expansion and Redistribution of Aedes-Borne Virus Transmission Risk with Climate Change. PLoS Negl. Trop. Dis. 2019, 13, e0007213. [Google Scholar] [CrossRef] [Green Version]
  71. Ciocchetta, S.; Prow, N.A.; Darbro, J.M.; Frentiu, F.D.; Savino, S.; Montarsi, F.; Capelli, G.; Aaskov, J.G.; Devine, G.J. The New European Invader Aedes (Finlaya) Koreicus: A Potential Vector of Chikungunya Virus. Pathog. Glob. Health 2018, 112, 107–114. [Google Scholar] [CrossRef] [PubMed]
  72. Baldacchino, F.; Arnoldi, D.; Lapère, C.; Rosà, R.; Montarsi, F.; Capelli, G.; Rizzoli, A. Weak Larval Competition Between Two Invasive Mosquitoes Aedes Koreicus and Aedes Albopictus (Diptera: Culicidae). J. Med. Entomol. 2017, 54, 1266–1272. [Google Scholar] [CrossRef]
  73. Harbach, R.E. Culex Pipiens: Species Versus Species Complex—Taxonomic History and Perspective. J. Am. Mosq. Control Assoc. 2012, 28, 10–23. [Google Scholar] [CrossRef]
  74. Werblow, A.; Klimpel, S.; Bolius, S.; Dorresteijn, A.W.C.; Sauer, J.; Melaun, C. Population Structure and Distribution Patterns of the Sibling Mosquito Species Culex Pipiens and Culex Torrentium (Diptera: Culicidae) Reveal Different Evolutionary Paths. PLoS ONE 2014, 9, e102158. [Google Scholar] [CrossRef] [Green Version]
  75. Di Luca, M.; Toma, L.; Boccolini, D.; Severini, F.; La Rosa, G.; Minelli, G.; Bongiorno, G.; Montarsi, F.; Arnoldi, D.; Capelli, G.; et al. Ecological Distribution and CQ11 Genetic Structure of Culex Pipiens Complex (Diptera: Culicidae) in Italy. PLoS ONE 2016, 11, e0146476. [Google Scholar] [CrossRef] [PubMed]
  76. Martinet, J.-P.; Ferté, H.; Failloux, A.-B.; Schaffner, F.; Depaquit, J. Mosquitoes of North-Western Europe as Potential Vectors of Arboviruses: A Review. Viruses 2019, 11, 1059. [Google Scholar] [CrossRef] [Green Version]
  77. Pages, N.; Huber, K.; Cipriani, M.; Chevallier, V.; Conraths, F.J.; Goffredo, M.; Balenghien, T. Scientific Review on Mosquitoes and Mosquito-borne Diseases. EFSA Support. Publ. 2009, 6, 1–97. [Google Scholar] [CrossRef]
  78. Hubálek, Z. Mosquito-Borne Viruses in Europe. Parasitol. Res. 2008, 103, 29–43. [Google Scholar] [CrossRef] [PubMed]
  79. Shimabukuro, P.H.F.; Galati, E.A.B. Lista de espécies de Phlebotominae (Diptera, Psychodidae) do Estado de São Paulo, Brasil, com comentários sobre sua distribuição geográfica. Biota Neotrop. 2011, 11, 685–704. [Google Scholar] [CrossRef] [Green Version]
  80. Galati, E.A.B.; Galvis-Ovallos, F.; Lawyer, P.; Léger, N.; Depaquit, J. An Illustrated Guide for Characters and Terminology Used in Descriptions of Phlebotominae (Diptera, Psychodidae). Parasite Paris Fr. 2017, 24, 26. [Google Scholar] [CrossRef] [Green Version]
  81. Busani, L.; Mughini Gras, L.; Romi, R.; Boccolini, D.; Severini, F.; Bongiorno, G.; Khoury, C.; Bianchi, R.; Gradoni, L.; Capelli, G. Zanzare, Flebotomi e Zecche: Atlante Bibliografico Delle Specie d’interesse Sanitario in Italia (1985–2009); Istituto Superiore di Sanità: Rome, Italy, 2012. [Google Scholar]
  82. Alkan, C.; Bichaud, L.; de Lamballerie, X.; Alten, B.; Gould, E.A.; Charrel, R.N. Sandfly-Borne Phleboviruses of Eurasia and Africa: Epidemiology, Genetic Diversity, Geographic Range, Control Measures. Antivir. Res. 2013, 100, 54–74. [Google Scholar] [CrossRef] [Green Version]
  83. Charrel, R.N. Emergence of Toscana Virus in the Mediterranean Area. World J. Virol. 2012, 1, 135. [Google Scholar] [CrossRef]
  84. EpiCentro Zecche—Istituto Superiore di Sanità. Available online: https://www.epicentro.iss.it/zecche/ (accessed on 24 October 2022).
  85. Huang, Y.-J.S.; Higgs, S.; Vanlandingham, D.L. Arbovirus-Mosquito Vector-Host Interactions and the Impact on Transmission and Disease Pathogenesis of Arboviruses. Front. Microbiol. 2019, 10, 22. [Google Scholar] [CrossRef]
  86. Iannetta, M.; Di Caro, A.; Nicastri, E.; Vairo, F.; Masanja, H.; Kobinger, G.; Mirazimi, A.; Ntoumi, F.; Zumla, A.; Ippolito, G. Viral Hemorrhagic Fevers Other than Ebola and Lassa. Infect. Dis. Clin. N. Am. 2019, 33, 977–1002. [Google Scholar] [CrossRef]
  87. Dantas-Torres, F.; Otranto, D. Seasonal Dynamics of Ixodes Ricinus on Ground Level and Higher Vegetation in a Preserved Wooded Area in Southern Europe. Vet. Parasitol. 2013, 192, 253–258. [Google Scholar] [CrossRef] [PubMed]
  88. Rizzoli, A.; Hauffe, H.C.; Tagliapietra, V.; Neteler, M.; Rosà, R. Forest Structure and Roe Deer Abundance Predict Tick-Borne Encephalitis Risk in Italy. PLoS ONE 2009, 4, e4336. [Google Scholar] [CrossRef] [Green Version]
  89. Kolodziejek, J.; Marinov, M.; Kiss, B.J.; Alexe, V.; Nowotny, N. The Complete Sequence of a West Nile Virus Lineage 2 Strain Detected in a Hyalomma Marginatum Marginatum Tick Collected from a Song Thrush (Turdus Philomelos) in Eastern Romania in 2013 Revealed Closest Genetic Relationship to Strain Volgograd 2007. PLoS ONE 2014, 9, e109905. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Pascucci, I.; Di Domenico, M.; Capobianco Dondona, G.; Di Gennaro, A.; Polci, A.; Capobianco Dondona, A.; Mancuso, E.; Cammà, C.; Savini, G.; Cecere, J.G.; et al. Assessing the Role of Migratory Birds in the Introduction of Ticks and Tick-Borne Pathogens from African Countries: An Italian Experience. Ticks Tick-Borne Dis. 2019, 10, 101272. [Google Scholar] [CrossRef] [PubMed]
  91. Hoffman, T.; Carra, L.G.; Öhagen, P.; Fransson, T.; Barboutis, C.; Piacentini, D.; Figuerola, J.; Kiat, Y.; Onrubia, A.; Jaenson, T.G.T.; et al. Association between Guilds of Birds in the African-Western Palaearctic Region and the Tick Species Hyalomma Rufipes, One of the Main Vectors of Crimean-Congo Hemorrhagic Fever Virus. One Health 2021, 13, 100349. [Google Scholar] [CrossRef] [PubMed]
  92. Walton, W.E.; Reisen, W.K. Influence of climate change on mosquito development and blood-feeding patterns. In Viral Infections and Global Change; Singh, S.K., Ed.; John Wiley & Sons, Inc: Hoboken, NJ, USA, 2013; pp. 35–56. ISBN 978-1-118-29746-9. [Google Scholar]
  93. IPCC. Climate Change 2022: Impacts, Adaptation and Vulnerability; Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change; Pörtner, H.-O., Roberts, D.C., Tignor, M., Poloczanska, E.S., Mintenbeck, K., Alegría, A., Craig, M., Langsdorf, S., Löschke, S., Möller, V., et al., Eds.; IPCC: Geneva, Switzerland, 2022. [Google Scholar]
  94. Sánchez-Seco, M.P.; Sierra, M.J.; Estrada-Peña, A.; Valcárcel, F.; Molina, R.; de Arellano, E.R.; Olmeda, A.S.; San Miguel, L.G.; Jiménez, M.; Romero, L.J.; et al. Widespread Detection of Multiple Strains of Crimean-Congo Hemorrhagic Fever Virus in Ticks, Spain. Emerg. Infect. Dis. 2022, 28, 394–402. [Google Scholar] [CrossRef]
Table 1. Epidemiological and clinical characteristics of arboviral infections in Italy.
Table 1. Epidemiological and clinical characteristics of arboviral infections in Italy.
ArbovirusVectorType of CirculationClinical FeaturesSevere Disease
West Nile virus (WNV)Culex pipiens, Aedes koreicusendemic, importedWest Nile Fever: fever, headache, nausea and vomiting, lymphadenopathies, rashWest Nile neuroinvasive disease: meningoencephalitis with disorientation, tremors, impaired vision, numbness, convulsions, paralysis, and coma
Usutu virus (USUV)Culex pipiens, Aedes albopictusendemicfever, headache, arthromyalgias, nausea and vomiting, lymphadenopathies, rashhigh fever, stiff neck, confusion, disorientation, coma, seizures, loss of vision, numbness, and paralysis.
Toscana virus (TOSV)Phlebotomus perniciosus,
Phlebotomus perfiliewi
endemicflu-like symptomsmeningoencephalitis, sensory polyradiculopathy, Guillain–Barrè syndrome, testicular involvement, myositis, and fasciitis
Sandfly Fever Sicilian virus (SFSV)Phlebotomus perniciosus;
Phlebotomus papatasi
endemicflu-like symptomssporadic neuroinvasive disease reported
Sandfly Fever Naples virus (SFNV)Phlebotomus perniciosus, Phlebotomus perfiliewiendemicflu-like symptomsuncommon
Tick-borne encephalitis virus (TBEV)Ixodes ricinus, Ixodes persulcatus, Dermacentor, Haemaphysalisendemic, importedhigh fever, severe headache, sore throat, tiredness, arthromyalgiasencephalitis, flaccid paralysis
Chikungunya virus (CHIKV)Aedes aegypti, Aedes albopictusimported, outbreaksfever, joint painrarely ophthalmological, neurological and heart complications
Dengue virus (DENV)Aedes aegypti, Aedes albopictusimported, outbreakssevere headache, eye pain, arthromyalgias, nausea and vomiting, rashshock, internal bleeding, and even death. More common in people with previous DENV infection.
Zika virus (ZIKV)Aedes aegypti, Aedes albopictus,
Culex pipiens
importedmaculopapular rash, arthromyalgias, headache, and conjunctivitis.Rarely Guillain–Barrè syndrome and neuroinvasive disease. Infection during pregnancy: teratogenic effects.
Vectors in bold represent the most competent vector.
Table 2. Incidence of endemic and imported arbovirosis in Italy 2010–2022.
Table 2. Incidence of endemic and imported arbovirosis in Italy 2010–2022.
2010201120122013201420152016201720182019202020212022 *
Endemic arbovirosis
WNV3 a14 b50 b69 b24 b60 b76 b57 b576 b53 b66 b55 b588 b
USUVNANANANANANANANA8 c1 a1 a2 a2 d
TOSV
neuroinvasive
NANANANANANA94 aNA89 a56 a36 a56 a100 a
TBEVNANANANANA5 b48 b24 b39 b37 b55 b14 a40 a
Imported arbovirosis
DENV50 a
47 a
79 a
142 a
79 a
105 a
106 a
94 a
108 a
185
19 a
(30) a
11 a
114 a
ZKV0 a0 a0 a0 a3 a4 a102 a26 a1 a4 a3 a0 a1 a
CHIKV7 a
2 a
5 a
3 a
37 a
8 a
17 a
5 a
(489) e
5 a
18 a
3 a
0 a
0 a
West Nile Virus (WNV), Usutu Virus (USUV), Toscana Virus (TOSV), Tick-Borne encephalitis Virus (TBEV), Dengue virus (DENV), Zika virus (ZKV), Chikungunya virus (CHIKV). The numbers in brackets represent the outbreaks. For TOSV, only neuroinvasive infections are reported. * 2022 data include cases up to October 3rd; a Epicentro ISS Data; b ECDC Surveillance and Disease Data; c Pacenti M et al. [15]; d ISS, IZS Teramo. Integrated Surveillance of West Nile and Usutu virus. Bulletin N. 20 of 2 November 2022; e ISS. Italy: Autochthonous Outbreaks of Chikungunya Virus Infection.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rossi, B.; Barreca, F.; Benvenuto, D.; Braccialarghe, N.; Campogiani, L.; Lodi, A.; Aguglia, C.; Cavasio, R.A.; Giacalone, M.L.; Kontogiannis, D.; et al. Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses 2023, 15, 368. https://doi.org/10.3390/v15020368

AMA Style

Rossi B, Barreca F, Benvenuto D, Braccialarghe N, Campogiani L, Lodi A, Aguglia C, Cavasio RA, Giacalone ML, Kontogiannis D, et al. Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses. 2023; 15(2):368. https://doi.org/10.3390/v15020368

Chicago/Turabian Style

Rossi, Benedetta, Filippo Barreca, Domenico Benvenuto, Neva Braccialarghe, Laura Campogiani, Alessandra Lodi, Camilla Aguglia, Rosario Alessandro Cavasio, Maria Laura Giacalone, Dimitra Kontogiannis, and et al. 2023. "Human Arboviral Infections in Italy: Past, Current, and Future Challenges" Viruses 15, no. 2: 368. https://doi.org/10.3390/v15020368

APA Style

Rossi, B., Barreca, F., Benvenuto, D., Braccialarghe, N., Campogiani, L., Lodi, A., Aguglia, C., Cavasio, R. A., Giacalone, M. L., Kontogiannis, D., Moccione, M., Malagnino, V., Andreoni, M., Sarmati, L., & Iannetta, M. (2023). Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses, 15(2), 368. https://doi.org/10.3390/v15020368

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop